1 Introduction Individuals diagnosed with type 2 diabetes mellitus (T2DM) face an increased risk of mortality and cardiovascular problems. SGLT2 inhibitors (SGLT-2i) have received approval to reduce blood glucose levels in adults with T2DM when used in conjunction with diet and exercise. In addition to lowering glucose, SGLT-2i offers additional benefits in addressing various aspects of metabolic syndrome, such as improving blood pressure, weight management, and lipid profiles.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Chun
Contact Chun, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack